Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Share-based Compensation: 2017-2021

Historic Share-based Compensation for Cogent Biosciences (COGT) over the last 5 years, with Dec 2021 value amounting to $3.9 million.

  • Cogent Biosciences' Share-based Compensation rose 344.80% to $3.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $11.7 million, marking a year-over-year increase of 94.22%. This contributed to the annual value of $39.7 million for FY2024, which is 29.78% up from last year.
  • Cogent Biosciences' Share-based Compensation amounted to $3.9 million in Q4 2021, which was up 11.23% from $3.5 million recorded in Q3 2021.
  • Cogent Biosciences' Share-based Compensation's 5-year high stood at $3.9 million during Q4 2021, with a 5-year trough of $282,000 in Q2 2017.
  • For the 3-year period, Cogent Biosciences' Share-based Compensation averaged around $1.7 million, with its median value being $877,500 (2019).
  • In the last 5 years, Cogent Biosciences' Share-based Compensation declined by 8.37% in 2019 and then skyrocketed by 345.69% in 2020.
  • Over the past 5 years, Cogent Biosciences' Share-based Compensation (Quarterly) stood at $460,000 in 2017, then skyrocketed by 96.09% to $902,000 in 2018, then declined by 6.65% to $842,000 in 2019, then grew by 2.85% to $866,000 in 2020, then soared by 344.80% to $3.9 million in 2021.
  • Its Share-based Compensation stands at $3.9 million for Q4 2021, versus $3.5 million for Q3 2021 and $2.6 million for Q2 2021.